Lidocain-Adrenalin (Epinephrine, Lidocaine Hydrochloride)

Lidocaine blocks voltage‑gated sodium channels on nerve fibers, stopping the transmission of pain signals. Epinephrine stimulates alpha‑adrenergic receptors on blood vessels, causing vasoconstriction. This reduces systemic absorption of lidocaine, extends its local effect, and minimizes bleeding during the procedure.

The appropriate dose of Lidocain-Adrenalin is determined by the prescribing clinician based on the specific procedure, patient weight, age, and clinical condition. Healthcare professionals calculate the volume and concentration needed to achieve effective anesthesia while staying within safety limits.

Safety data for Lidocain-Adrenalin in pregnancy and lactation are limited. It should only be used when the potential benefit to the mother outweighs any possible risk to the fetus or infant, and it should be administered under close medical supervision.

To place an order, submit an enquiry on the product page at gnhindia.com specifying the required quantity. GNH India works with hospitals, pharmacies, and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details (including cold‑chain if needed), and required import documentation.

Plain lidocaine provides rapid local anesthesia but has a shorter duration and may cause more bleeding. Adding epinephrine creates a vasoconstrictive effect that prolongs anesthesia, reduces systemic absorption, and minimizes intra‑procedural bleeding, making the combination preferable for longer or more vascular procedures.

Lidocain-Adrenalin should be stored at ambient temperature, preferably below 25 °C. Keep the vial in its original packaging, protect it from direct light and moisture, and avoid freezing. Inspect the solution for particulate matter or discoloration before use.

The product is administered by a qualified healthcare professional via subcutaneous or intramuscular injection. The injection site is selected based on the intended procedure, and the solution is delivered using aseptic technique to ensure effective local anesthesia.

Serious risks include severe allergic reactions (anaphylaxis), cardiac arrhythmias or hypertension due to epinephrine, methemoglobinemia, and central nervous system toxicity such as seizures. Prompt recognition and treatment of these events are essential.

Patients with a known hypersensitivity to lidocaine, epinephrine, or any component of the formulation should avoid the product. It is also contraindicated in individuals with severe cardiovascular disease, uncontrolled hyperthyroidism, or those taking monoamine oxidase inhibitors without appropriate medical supervision.